Schistosomiasis project gets $1.15M boost from Gates Foundation

08/26/2013 | Pharmaceutical Business Review Online

An international public-private partnership that aims to develop a pediatric treatment for schistosomiasis, or bilharzia, received a $1.15 million grant from the Bill & Melinda Gates Foundation. Members of the consortium include Astellas Pharma, Merck KGaA and the Swiss Tropical and Public Health Institute.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care